T serotyping and genomic profile of erythromycin-resistant or -sensitive Streptococcus pyogenes isolated in Campania Region, Italy

Journal of Chemotherapy

Volumn 17, Issue 2, 2005, Pages 131-137

  Catalanotti, P ^a   Catania, M R ^b   Lucido, M ^a   Martini, S ^a   Galle F ^b   Ortega De Luna, L ^b   Rossano, F ^b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Bacterial invasiveness; Erythromycin; PFGE; PrtF1 gene; Streptococcus pyogenes

Indexed keywords

ERYTHROMYCIN;

AGGLUTINATION TEST; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DISEASE SEVERITY; GENETIC POLYMORPHISM; GENOMICS; HUMAN; HUMAN CELL; ITALY; NECROTIZING FASCIITIS; NONHUMAN; PHARYNGITIS; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPING; STREPTOCOCCUS PYOGENES;

EID: 19544384884     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.2.131     Document Type: Article

References (48)

1. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 470-511.
2. Horn DL, Zabriskie JB, Austrian R et al. Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis 1998; 6: 1341-1345.
3. Orrling A, Stjernquist-Desatnik A, Schalèn C, Kamme C. Treatment failure in streptococcal pharyngotonsillitis. An attempt to identify penicillin tolerant Streptococcus pyogenes. Scand J Infect Dis 1996; 28: 143-147.
4. Pichichero ME. Streptococcal pharyngitis: is penicillin still the right choice? Compr Ther 1996; 22: 782-787.
5. van Asselt GL, Mouton RP, van Boven CPA. Penicillin tolerance and treatment failure in group A streptococcal pharyngotonsillitis. Eur J Clin Microbiol Infect Dis 1996; 15: 107-115.
6. Brook I, Yocum P, Shah K. β-lactamase producing Bacteroldes species recovered from children: possible due to failure of penicillin treatment. JAMA 1980; 244: 1696-1699.
7. Gastanaduy AS, Kaplan EL, Huwe BB, McKay C, Wannamaker LW. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet 1980; 6: 498-502.
8. Tuner K, Nord CE. The role of β-lactamase-producing Bacteroides in recurrent tonsillitis. Acta Otolaryngol 1983; 95: 191-192.
9. Mazzaglia G, Greco S, Lando C, Cucinotta G, Caputi AP. Adult acute upper respiratory tract infections in Sicily: pattern of antibiotic drug prescription in primary care. J Antimicrob Chemother 1998; 41: 256-266.
10. Morita JY, Kahn E, Thompson T et al. Impact of azithromycin on oropharyngeal carriage of group A Streptococcus and nasopharyngeal carriage of macrolide-resistant Streptococcus pneumoniae. Pediatr Infect Dis J 2000; 9: 41-46.
11. Molinari G, Talay SR, Valentin-Weigand P, Rohde M, Chhatwal GS. The fibronectin-binding protein of Streptococcus pyogenes, Sfbl, is involved in the intemalization of group A streptococci by epithelial cells. Infect Immun 1997; 65: 1357-1363.
12. Ozeri V, Rosenshine I, Mosher DF, Fassler R, Hanski E. Roles of integrins and fibronectin in the entry of Streptococcus pyogenes into cells via protein F1. Mol Microbiol 1998; 30: 625-637.
13. Lowbury EJL, Hurst L. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin and spiramycin. J Clin Pathol 1959; 12: 163-169.
14. Duval J. Evolution and epidemiology of MLS resistance. J Antimicrob Chemother 1985; 16 (suppl. A): 137-149.
15. Mitsuhaschi S, Inoue M, Saito K, Nakae M. Drug resistance in Streptococcus pyogenes strains isolated in Japan. In: Schlessinger D, ed. Microbiology 1982. Washington, DC: ASM Press. 1982: 151-154.
16. Zampaloni C, Vitali LA, Prenna M, Toscano MA, Tempera G, Ripa S. Erythromycin resistance in Italian isolates of Streptococcus pyogenes and correlation with pulsed-field gel electrophoresis analysis. Microb Drug Resist 2002; 8: 39-44.
17. Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J 1994: 13: 1075-1078.
18. Bergman M, Huikko S, Pihlajamaki M, Laippala P, Palva E, Huovinen P, Seppala H; Finnish Study Group for Antimicrobial Resistance (FiRe Network). Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis 2004; 3: 1251-1256.
19. Hsueh PR, Teng LJ, Lee LN et al. Increased prevalence of erythromycin resistance in streptococci: substantial upsurge in erythromycin-resistant M phenotype in Streptococcus pyogenes (1979-1998) but not in Streptococcus pneumoniae (1985-1999) in Taiwan. Microb Drug Resist 2002; 8: 27-33.
20. Borzani M, De Luca M, Varotto F. A survey of susceptibility to erythromycin amongst Streptococcus pyogenes isolates in Italy. J Antimicrob Chemother 1997; 40: 457-458.
21. Cornaglia G, Ligozzi M, Mazzariol A, Valentini M, Orefici G, Fontana R. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993-1995. The Italian Surveillance Group for Antimicrobial Resistance. Emerg Infect Dis 1996; 2: 339-342.
22. Varaldo PE, Debbia EA, Nicoletti G et al. Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Clin Infect Dis 1999; 29: 869-873.
23. Seppälä H, Skurnik M, Soini H, Roberts M, Huovinen P. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob Agents Chemother 1998; 42: 257-262.
24. Giovanetti E, Brenciani A, Vecchi M, Manzin A, Varaldo PE. Prophage association of mef(A) elements encoding efflux-mediated erythromycin resistance in Streptococcus pyogenes. J Antimicrob Chemother 2005; 55: 445-451.
25. Giovanetti E, Brenciani A, Burioni R, Varaldo PE. A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes. Antimicrob Agents Chemother 2002; 46: 3750-3755.
26. Isberg RR, Falcow SA. A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K12. Nature (Lond.) 1985; 317: 262-264.
27. Rubens CE, Smith S, Hulse M, Chi EY, van Belle G. Respiratory epithelial cell invasion by group B streptococci. Infect Immun 1992; 60: 5157-5163.
28. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: tenth informational supplement. NCCLS Document M100-S10 (M7), 2000. National Committee for Clinical Laboratory Standards, Wayne, Pa.
29. Giovanetti E, Montanari MP, Mingoia M, Varaldo PE. Phenotypes and Genotypes of Erythromycin-Resistant Streptococcus pyogenes Strains in Italy and Heterogeneity of Inducibly Resistant Strains. Antimicrob Agents Chemother 1999; 43: 1935-1940.
30. Neeman R, Keller N, Barzilai A, Korenman Z, Sela S. Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet 1998; 352: 1974-1977.
31. Spinaci C, Magi G, Zampaloni C et al. Genetic diversity of cell-invasive erythromycin-resistant and -susceptible group A streptococci determined by analysis of the RD2 region of the prtF1 gene. J Clin Microbiol 2004; 42: 639-644.
32. Chelossi E, Platè M, De Leo C, Schito GC. Analisi genotipica di Streptococcus pyogenes eritromicina-resistenti isolati recentemente in Italia. Giomale Italiano di Microbiologia Medica Odontoiatrica e Clinica (GIMMOC) 1998; 3: 9-20.
33. Bruno R, Sturla C, Tosi MT et al. Monitoraggio della sensibilità in vitro di S. pyogenes a macrolidl e lincosamidi basata sull'uso di Internet. GIMMOC 2001; 5: 21-29.
34. Caparon MG, Stephens DS, Olsen A, Scott JR. Role of M protein in adherence of group A streptococci. Infect Immun 1991; 59: 1811-1817.
35. Cristiano L, Bonzi D, Noris C et al. Streptococchi beta-emolitici di gruppo A: rapido incremento di ceppi resistenti all'eritromicina in un'area del Nord Italia. Microbiologia Medica 1996; 11: 30-33.
36. Cantón R, Mazzariol A, Morosini Ml. Baquero F, Cornaglia G. Telithromycin activity is reduced by efflux in Streptococcus pyogenes. J Antimicrob Chemother 2005; 55: 489-495.
37. Ross JI, Eady EA, Cove JH, Cunliffe WJ, Baumberg S, Wotton JC. Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport supergene family. Mol Microbiol 1990; 4: 1207-1214.
38. Musser JM, Kapur V, Szeto J et al. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 1995; 63: 994-1003.
39. Facinelli B, Spinaci C, Magi G, Giovanetti E, Varaldo PE. Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet 2001; 358: 3-4.
40. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 9: 2233-2239.
41. Cocuzza C, Blandino G, Mattina R, Nicoletti F, Nicoletti G. Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania. Microb Drug Resist 1997; 3: 379-384.
42. Savoia D, Avanzini C, Bosio K et al. Macrolide resistance in group A streptococci. J Antimicrob Chemother 2000: 45: 41-47.
43. Schito GC, Pesce A, Marchese A. The role of macrolides in Streptococcus pyogenes pharyngitis. J Antimicrob Chemother 1997; 39: 562-565.
44. Seppälä H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. New Engl J Med 1997; 337: 441-446.
45. Galdiero F, Catalanotti P, Ianniello R, Motta G, Antonelli C. Studio della flora batterica faringo-tonsillare, delle principali funzioni granulocitarie e di alcune sottopopolazioni linfocitarie prima e dopo tonsillectomia. In: Motta G, ed. L'adenotonsillectomia. Padova, Italy. Piccin 97108.
46. Brook I, Shah K. Bacteriology of adenoids and tonsils in children with recurrent adenotonsillitis. Ann Otol Rhinol Laryngol; 2001; 110: 844-848.
47. Brook I. Microbiology and management of peritonsillar, retropharyngeal, and parapharyngeal abscesses. J Oral Maxillofac Surg 2004; 62: 1545-1550.
48. Hoban DJ, Bouchillon SK, Johnson JL. et al. Comparative in vitro potency of amoxycillin-clavulanic acid and four oral agents against recent North American clinical isolates from a global surveillance study. Int J Antimicrob Agents 2003; 21: 425-433.